` IOLCP (IOL Chemicals and Pharmaceuticals Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

IOLCP
vs
BSE Sensex 30

Over the past 12 months, IOLCP has underperformed BSE Sensex 30, delivering a return of -19% compared to the BSE Sensex 30's 2% growth.

Stocks Performance
IOLCP vs BSE Sensex 30

Loading

Performance Gap
IOLCP vs BSE Sensex 30

Loading
IOLCP
BSE Sensex 30
Difference

Performance By Year
IOLCP vs BSE Sensex 30

Loading
IOLCP
BSE Sensex 30
Add Stock

Competitors Performance
IOL Chemicals and Pharmaceuticals Ltd vs Peers

BSE Sensex 30
IOLCP
LLY
JNJ
NOVO B
ROG
Add Stock

IOL Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
18.1B INR
Industry
Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

IOLCP Intrinsic Value
94.45 INR
Undervaluation 35%
Intrinsic Value
Price
Back to Top